Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events)
Debabrata Mukherjee, Kim A. Eagle, Eva Kline‐Rogers, Laurent J. Feldman, Jean-Michel Juliard, Giancarlo Agnelli, Andrzej Budaj, Álvaro Avezum, Jeanna Allegrone, Gordon FitzGerald, Philippe Gabríel Steg (2007). Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events). , 100(1), DOI: https://doi.org/10.1016/j.amjcard.2007.02.046.
Article324 days agoImpact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry
Michael J. Lim, Frederick A. Spencer, Joel M. Gore, Omar Dabbous, Giancarlo Agnelli, Eva Kline‐Rogers, Donna DiBenedetto, Kim A. Eagle, Rajendra H. Mehta (2005). Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. , 26(11), DOI: https://doi.org/10.1093/eurheartj/ehi139.
Article324 days agoOutcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes
Omar Dabbous, Frederick A. Anderson, Joel M. Gore, Kim A. Eagle, Keith A.A. Fox, Rajendra H. Mehta, Robert J. Goldberg, Giancarlo Agnelli, Philippe Gabríel Steg (2007). Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. , 94(2), DOI: https://doi.org/10.1136/hrt.2006.105783.
Article324 days ago